Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire (Fri, 20-Feb 4:05 PM ET)
Pulse Biosciences slips despite Q4 beat after deal to sell shares
Seeking Alpha News (Fri, 20-Feb 10:22 AM ET)
Pulse Biosciences Set to Spotlight Nanosecond Pulsed Field Ablation at Major Healthcare Conference
Market Chameleon (Fri, 20-Feb 3:39 AM ET)
TipRanks (Fri, 20-Feb 8:20 AM ET)
Mizuho Securities Sticks to Their Buy Rating for Pulse Biosciences (PLSE)
TipRanks (Fri, 20-Feb 7:45 AM ET)
Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference
Business Wire (Fri, 20-Feb 7:00 AM ET)
Pulse Biosciences targets CE Mark submission in 2026 as nPulse platform advances clinical milestones
Seeking Alpha News (Fri, 20-Feb 2:55 AM ET)
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results
Business Wire (Thu, 19-Feb 4:05 PM ET)
Market Chameleon (Fri, 6-Feb 6:06 AM ET)
Business Wire (Thu, 5-Feb 7:00 PM ET)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Pulse Biosciences trades on the NASDAQ stock market under the symbol PLSE.
As of February 25, 2026, PLSE stock price climbed to $19.21 with 373,776 million shares trading.
PLSE has a beta of 0.80, meaning it tends to be less sensitive to market movements. PLSE has a correlation of 0.05 to the broad based SPY ETF.
PLSE has a market cap of $1.30 billion. This is considered a Small Cap stock.
Last quarter Pulse Biosciences reported $264,000 in Revenue and -$.26 earnings per share. This beat revenue expectation by $14,000 and missed earnings estimates by -$.01.
In the last 3 years, PLSE traded as high as $26.30 and as low as $2.36.
The top ETF exchange traded funds that PLSE belongs to (by Net Assets): IWM, VTI, IWO, VXF, SCHA.
PLSE has underperformed the market in the last year with a price return of +2.4% while the SPY ETF gained +17.3%. However, in the short term, PLSE had mixed performance relative to the market. It has outperformed in the last 3 months, returning +46.8% vs +3.9% return in SPY. But in the last 2 weeks, PLSE shares have been beat by the market, returning -19.7% compared to an SPY return of +0.1%.
PLSE support price is $17.94 and resistance is $20.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLSE shares will trade within this expected range on the day.